Stay updated on Gantenerumab Long-term Safety in AD Clinical Trial

Sign up to get notified when there's something new on the Gantenerumab Long-term Safety in AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gantenerumab Long-term Safety in AD Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record presents details of the gantenerumab Alzheimer’s disease study, including its terminated status, study design, eligibility criteria, locations, outcome measures, and posted results information. It also includes the study protocol and information on requesting participant-level data.
    Difference
    68%
    Check dated 2026-11-11T02:16:42.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-04T00:51:20.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    An NIH site-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:54:15.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T01:03:58.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study content, showing an access-denied message and basic site chrome rather than the full study record details.
    Difference
    17%
    Check dated 2026-09-23T01:06:16.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.7.0 is now displayed on the page, replacing the previous v3.6.6. This reflects a new release of the website's rendering components rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-09-16T00:08:42.000Z thumbnail image

Stay in the know with updates to Gantenerumab Long-term Safety in AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gantenerumab Long-term Safety in AD Clinical Trial page.